KR101517763B1 - Dissolution inhibitor and chemically amplified photoresist composition including the same - Google Patents

Dissolution inhibitor and chemically amplified photoresist composition including the same Download PDF

Info

Publication number
KR101517763B1
KR101517763B1 KR1020080033586A KR20080033586A KR101517763B1 KR 101517763 B1 KR101517763 B1 KR 101517763B1 KR 1020080033586 A KR1020080033586 A KR 1020080033586A KR 20080033586 A KR20080033586 A KR 20080033586A KR 101517763 B1 KR101517763 B1 KR 101517763B1
Authority
KR
South Korea
Prior art keywords
weight
parts
formula
dissolution inhibitor
photosensitive polymer
Prior art date
Application number
KR1020080033586A
Other languages
Korean (ko)
Other versions
KR20090108255A (en
Inventor
김정우
김덕배
김재현
Original Assignee
주식회사 동진쎄미켐
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 동진쎄미켐 filed Critical 주식회사 동진쎄미켐
Priority to KR1020080033586A priority Critical patent/KR101517763B1/en
Publication of KR20090108255A publication Critical patent/KR20090108255A/en
Application granted granted Critical
Publication of KR101517763B1 publication Critical patent/KR101517763B1/en

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/0045Photosensitive materials with organic non-macromolecular light-sensitive compounds not otherwise provided for, e.g. dissolution inhibitors
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/0047Photosensitive materials characterised by additives for obtaining a metallic or ceramic pattern, e.g. by firing
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/20Exposure; Apparatus therefor

Abstract

포토리쏘그래피 공정에서 노광부와 비노광부의 용해도 차이를 증가시켜 라인 에지 러프니스(Line edge roughness)을 개선시킬 수 있는 용해억제제 및 이를 포함하는 화학 증폭형 레지스트 조성물이 개시된다. 상기 용해억제제는 하기 화학식(여기서, R1은 C1 ~ C30의 선형, 분지형, 단일환형, 또는 다환형의 알킬기이고, R2는 C1 ~ C20의 선형, 분지형, 단일환형, 또는 다환형의 알킬기이다)의 구조를 가진다.Disclosed is a dissolution inhibitor capable of improving the line edge roughness by increasing the solubility difference between an exposed portion and a non-exposed portion in a photolithography process, and a chemically amplified resist composition comprising the dissolution inhibitor. The dissolution inhibitors include the following formulas (wherein, R 1 is a linear, branched, single ring, or the alkyl group of the ring-shaped of C1 ~ C30, R 2 is a linear C1 ~ C20 linear, branched, single ring, or the annular Alkyl group).

Figure 112008025914823-pat00001
Figure 112008025914823-pat00001

또한, 상기 포토레지스트 조성물은, 감광성 고분자 3 내지 30 중량%; 상기 감광성 고분자 100 중량부에 대하여 1 내지 30 중량부의 상기 화학식으로 표시되는 용해억제제; 상기 감광성 고분자 100 중량부에 대하여 0.05 내지 10 중량부의 광산발생제; 및 나머지 유기용매를 포함한다.The photoresist composition may further comprise 3 to 30% by weight of a photosensitive polymer; A dissolution inhibitor represented by the above formula in an amount of 1 to 30 parts by weight based on 100 parts by weight of the photosensitive polymer; 0.05 to 10 parts by weight of a photoacid generator based on 100 parts by weight of the photosensitive polymer; And the remaining organic solvent.

용해억제제, 화학증폭형 포토레지스트 조성물, 라인 에지 러프니스 A dissolution inhibitor, a chemically amplified photoresist composition, a line edge roughness

Description

용해억제제 및 이를 포함하는 화학 증폭형 포토레지스트 조성물 {Dissolution inhibitor and chemically amplified photoresist composition including the same}Dissolution inhibitor and chemically amplified photoresist composition including the same [0002]

본 발명은 용해억제제에 관한 것으로서, 더욱 상세하게는 포토리쏘그래피 공정을 이용한 미세 패턴의 형성에 있어서 노광부와 비노광부의 용해도 차이를 증가시켜 라인 에지 러프니스(Line edge roughness)을 개선시킬 수 있는 용해억제제 및 이를 포함하는 화학 증폭형 레지스트 조성물에 관한 것이다.The present invention relates to a dissolution inhibitor, and more particularly, to a dissolution inhibitor which can improve the line edge roughness by increasing the difference in solubility between the exposed portion and the non-exposed portion in the formation of a fine pattern using a photolithography process Dissolution inhibitor and a chemically amplified resist composition containing the same.

일반적으로, 포토리쏘그래피 공정에 사용되는 화학증폭형 포토레지스트 조성물은, 산(acid)과 반응하여 현상액(developer)에 대한 용해도가 변화하는 감광성 고분자, 빛의 조사에 의해 산을 발생시키는 광산발생제(photo-acid generator) 및 유기용매를 포함하며, 노광부에서 발생한 산이, 감광성 고분자의 탈보호 반응을 유발시킴으로써, 노광부와 비노광부의 용해도 차이를 증가시킨다. 상기 포토레지스트 조성물은, 비노광부를 더욱 단단하게 만들어, 견고하고 슬로프(slope)가 적은 포토 레지스트 패턴을 형성하기 위하여, 물 또는 현상액에 대하여 불용성인 용해억제제를 더욱 포함하기도 한다.Generally, a chemically amplified photoresist composition used in a photolithography process includes a photosensitive polymer that reacts with an acid to change its solubility to a developer, a photoacid generator that generates an acid upon irradiation of light (photo-acid generator) and an organic solvent. The acid generated in the exposure part induces the deprotection reaction of the photosensitive polymer, thereby increasing the solubility difference between the exposed part and the non-exposed part. The photoresist composition may further include a dissolution inhibitor which is insoluble in water or a developer so as to make the unexposed portion harder and to form a firm and slope-less photoresist pattern.

따라서, 본 발명의 목적은, ArF 등의 다양한 방사선을 노광원으로 사용하는 포토리쏘그래피 공정에서, 노광부와 비노광부의 용해도 차이를 증가시켜 라인 에지 러프니스를 개선시킬 수 있는 용해억제제 및 이를 포함하는 화학 증폭형 레지스트 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a dissolution inhibitor which can improve the line edge roughness by increasing the difference in solubility between the exposed portion and the non-exposed portion in a photolithography process using various radiation such as ArF as an exposure source and the like To provide a chemically amplified resist composition.

본 발명의 다른 목적은, 용해억제제의 양을 조절하여 노광에 의하여 발생한 산이 확산되는 정도를 조절할 수 있고, 또한, 현상액(Developer)과의 친화력을 높일 수 있어 라인 에지 러프니스를 개선시킬 수 있는 용해억제제 및 이를 포함하는 화학 증폭형 레지스트 조성물을 제공하는 것이다.It is another object of the present invention to provide a method for preparing a resist composition which can control the degree of diffusion of an acid generated by exposure by controlling the amount of a dissolution inhibitor and can improve the affinity with a developer and can improve the line edge roughness And a chemically amplified resist composition containing the same.

상기 목적을 달성하기 위하여, 본 발명은 하기 화학식으로 표시되는 용해억제제를 제공한다. In order to achieve the above object, the present invention provides a dissolution inhibitor represented by the following formula:

[화학식 1][Chemical Formula 1]

Figure 112008025914823-pat00002
Figure 112008025914823-pat00002

상기 화학식 1에서, R1은 C1 ~ C30의 선형, 분지형, 단일환형, 또는 다환형의 알킬기이고, R2는 C1 ~ C20의 선형, 분지형, 단일환형, 또는 다환형의 알킬기이다.R 1 is a linear, branched, monocyclic or polycyclic alkyl group having 1 to 30 carbon atoms and R 2 is a linear, branched, monocyclic or polycyclic alkyl group having 1 to 20 carbon atoms.

또한, 본 발명은 감광성 고분자 3 내지 30 중량%; 상기 감광성 고분자 100 중량부에 대하여 1 내지 30 중량부의 상기 화학식 1로 표시되는 용해억제제; 상기 감광성 고분자 100 중량부에 대하여 0.05 내지 10 중량부의 광산발생제; 및 나머지 유기용매를 포함하는 포토레지스트 조성물을 제공한다. 또한, 본 발명은 (a) 상기 포토레지스트 조성물을 기판 상부에 도포하여 포토레지스트막을 형성하는 단계; (b) 상기 포토레지스트막을 소정 패턴으로 노광하는 단계; (c) 상기 노광된 포토레지스트막을 가열하는 단계; 및 (d) 상기 가열된 포토레지스트막을 현상하여 원하는 패턴을 얻는 단계를 포함하는 포토레지스트 패턴의 형성방법을 제공한다. Also, the present invention provides a photosensitive composition comprising 3 to 30% by weight of a photosensitive polymer; 1 to 30 parts by weight of a dissolution inhibitor represented by the above formula (1) based on 100 parts by weight of the photosensitive polymer; 0.05 to 10 parts by weight of a photoacid generator based on 100 parts by weight of the photosensitive polymer; And a remaining organic solvent. (A) applying the photoresist composition on a substrate to form a photoresist film; (b) exposing the photoresist film to a predetermined pattern; (c) heating the exposed photoresist film; And (d) developing the heated photoresist film to obtain a desired pattern.

본 발명에 따른 용해억제제 및 이를 포함하는 화학 증폭형 포토레지스트 조성물은, 포토리쏘그래피 공정에서 노광부와 비노광부의 용해도 차이를 증가시킬 수 있는 용해억제제 구조 내에 질소(Nitrogen)원자를 함유하고 있어 용해억제제의 양을 조절함으로서 노광에 의하여 산이 확산되는 정도를 조절할 수 있고, 또한, 용해억제제 구조 내에 수산화(hydroxyl)기를 포함하고 있어 현상액(Developer)과의 친화력을 높일 수 있어 라인 에지 러프니스(Line edge roughness) 개선에 효과적이다.The dissolution inhibitor and the chemically amplified photoresist composition containing the same according to the present invention contain nitrogen atoms in the dissolution inhibitor structure which can increase the difference in solubility between the exposed and unexposed portions in the photolithography process, By controlling the amount of the inhibitor, it is possible to control the degree of diffusion of the acid by exposure. Further, since the hydroxyl group is contained in the structure of the dissolution inhibitor, the affinity with the developer can be increased, and the line edge roughness roughness.

이하, 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.

본 발명에 따른 용해억제제는, 하기 화학식 1의 구조를 가진다.The dissolution inhibitor according to the present invention has a structure represented by the following formula (1).

Figure 112008025914823-pat00003
Figure 112008025914823-pat00003

상기 화학식 1에서, R1은 C1 ~ C30(즉, 탄소수 1 내지 30)의 선형, 분지형, 단일환형, 또는 다환형의 알킬기로서, 필요에 따라, R1은 히드록시기, 할로겐기, 예를 들면 플루오르기 등으로 치환된 알킬기일 수 있고, R2는 C1 ~ C20(즉, 탄소수 1 내지 20)의 선형, 분지형, 단일환형, 또는 다환형의 알킬기로서, 필요에 따라, 할로겐기, 히드록시기 등의 치환기, 에테르기, 에스테르기 등을 포함할 수 있으며, 예를 들면 에테르기 또는 에스테르기를 포함하는 C5 ~ C10의 알킬기 또는 환형 알 킬기일 수 있다. 바람직하게는, R2는 분지형, 단일환형, 또는 다환형의 벌키한 알킬기이다.In the above formula (1), R 1 is a linear, branched, monocyclic or polycyclic alkyl group having from 1 to 30 carbon atoms (that is, having from 1 to 30 carbon atoms), wherein R 1 is a hydroxyl group, a halogen group, R 2 is a linear, branched, monocyclic or polycyclic alkyl group having from 1 to 20 carbon atoms (that is, having from 1 to 20 carbon atoms), and may optionally be substituted with a halogen group, a hydroxy group, etc. An ether group, an ester group, and the like, and may be, for example, a C5-C10 alkyl group or a cyclic alkyl group containing an ether group or an ester group. Preferably, R 2 is a branched, monocyclic, or polycyclic, bulky alkyl group.

상기 R1의 구체적인 예로는,

Figure 112008025914823-pat00004
,
Figure 112008025914823-pat00005
,
Figure 112008025914823-pat00006
,
Figure 112008025914823-pat00007
,
Figure 112008025914823-pat00008
,
Figure 112008025914823-pat00009
등을 예시할 수 있고, 상기 R2의 구체적인 예로는,
Figure 112008025914823-pat00010
,
Figure 112008025914823-pat00011
,
Figure 112008025914823-pat00012
,
Figure 112008025914823-pat00013
,
Figure 112008025914823-pat00014
,
Figure 112008025914823-pat00015
등을 예시할 수 있다. (여기서,
Figure 112008025914823-pat00016
은 연결부(connecting bond)를 나타낸다)Specific examples of R < 1 >
Figure 112008025914823-pat00004
,
Figure 112008025914823-pat00005
,
Figure 112008025914823-pat00006
,
Figure 112008025914823-pat00007
,
Figure 112008025914823-pat00008
,
Figure 112008025914823-pat00009
And specific examples of R < 2 > include, for example,
Figure 112008025914823-pat00010
,
Figure 112008025914823-pat00011
,
Figure 112008025914823-pat00012
,
Figure 112008025914823-pat00013
,
Figure 112008025914823-pat00014
,
Figure 112008025914823-pat00015
And the like. (here,
Figure 112008025914823-pat00016
Represents a connecting bond)

본 발명에 따른 화학식 1로 표시되는 용해억제제의 구체적인 예로는,

Figure 112008025914823-pat00017
(화학식 1a),
Figure 112008025914823-pat00018
(화학식 1b),
Figure 112008025914823-pat00019
(화학식 1c),
Figure 112008025914823-pat00020
(화학식 1d),
Figure 112008025914823-pat00021
(화학식 1e),
Figure 112008025914823-pat00022
(화학식 1f) 등을 예시할 수 있다.As specific examples of the dissolution inhibitor represented by the formula (1) according to the present invention,
Figure 112008025914823-pat00017
(Formula 1a),
Figure 112008025914823-pat00018
(1b),
Figure 112008025914823-pat00019
(Formula 1c),
Figure 112008025914823-pat00020
(1d),
Figure 112008025914823-pat00021
(1e),
Figure 112008025914823-pat00022
(Formula (1f)), and the like.

상기 화학식 1로 표시되는 용해억제제는, 노광부에서는 용해를 촉진시키지만 반대로 비노광부에서는 용해를 억제시키는 작용을 하므로 일반적인 용해억제제와 동일한 개념을 가지고 있다. 특징적으로, 상기 화학식 1로 표시되는 용해억제제는, 구조 내에 질소(Nitrogen)원자를 함유하고 있어, 용해억제제의 양을 조절하여 노광에 의하여 산이 확산되는 정도를 조절할 수 있어 비노광부의 탈보호기반응을 감소시킬 수 있기 때문에, 비노광부의 보호기들이 용해억제의 작용을 한다. 또한, 구조 내에 수산화(hydroxyl)기를 포함하고 있어 현상액(Developer)과의 친화력을 높일 수 있어 라인 에지 러프니스(Line edge roughness) 개선에 효과적이다.The dissolution inhibitor represented by the above-described formula (1) has the same concept as a general dissolution inhibitor because it accelerates dissolution in the exposed part but on the contrary, acts to inhibit dissolution in the unexposed part. Characteristically, the dissolution inhibitor represented by the above-mentioned formula (1) contains nitrogen atoms in the structure, and the degree of dissolution of the acid by exposure can be controlled by controlling the amount of the dissolution inhibitor so that the deprotection reaction of the non- The protective groups of the non-visible portion act as dissolution inhibiting agents. In addition, since it contains a hydroxyl group in the structure, affinity with a developer can be increased, and it is effective in improving line edge roughness.

본 발명에 따른 상기 화학식 1로 표시되는 용해억제제는 다음과 같이 합성될 수 있다. 예를 들면, 하기 반응식 1에 나타낸 바와 같이, 디이소시아네이트기를 가진 화합물과 수산화기를 가진 화합물을 질소 조건에서 반응시켜 중간체를 생성하고, 생성된 중간체를 녹말(starch)과 반응시켜 본 발명의 용해억제제를 제조할 수 있다.The dissolution inhibitor represented by Formula 1 according to the present invention can be synthesized as follows. For example, as shown in Reaction Scheme 1 below, a compound having a diisocyanate group and a compound having a hydroxyl group are reacted under a nitrogen condition to produce an intermediate, and the resulting intermediate is reacted with starch to obtain a dissolution inhibitor of the present invention Can be manufactured.

Figure 112008025914823-pat00023
Figure 112008025914823-pat00023

상기 반응식 1에서, R1 및 R2는 상기 화학식 1에서 정의한 바와 같다.In the above Reaction Scheme 1, R 1 and R 2 are as defined in Formula 1 above.

상기 디이소시아네이트기를 가진 화합물의 구체적인 예로는,

Figure 112008025914823-pat00024
(화학식 2a),
Figure 112008025914823-pat00025
(화학식 2b),
Figure 112008025914823-pat00026
(화학식 2c),
Figure 112008025914823-pat00027
(화학식 2d),
Figure 112008025914823-pat00028
(화학식 2e),
Figure 112008025914823-pat00029
(화학식 2f) 등을 예시할 수 있다.As specific examples of the compound having a diisocyanate group,
Figure 112008025914823-pat00024
(Formula 2a),
Figure 112008025914823-pat00025
(Formula 2b),
Figure 112008025914823-pat00026
(Formula 2c),
Figure 112008025914823-pat00027
(Formula 2d),
Figure 112008025914823-pat00028
(Formula 2e),
Figure 112008025914823-pat00029
(Formula 2f), and the like.

상기 반응은 반응물을 n-메틸피롤리덴(NMP, N-methylpyrrolidine)에 용해시킨 후, n-부틸아민(n-butylamine)을 첨가하여 반응시키며, 반응종료 후, 생성물을 메탄올(methanol)로 세척하고, 메틸렌클로라이드(methylenechloride)로 추출하고 분리한 다음, 무수 마그네슘 설페이트(anhydrous magnesium sulfate)에 여과시키고, 그 여액을 감압증류기에 넣고, 메틸렌클로라이드를 증발시킨 후, 실리카겔을 이용한 컬럼 크로마토그래피를 통해서 생성물을 분리하는 과정을 포함한다.The reaction is carried out by dissolving the reaction product in n-methylpyrrolidine (NMP), adding n-butylamine to the reaction, and after completion of the reaction, the product is washed with methanol The mixture was extracted with methylenechloride, separated, and then filtered through anhydrous magnesium sulfate. The filtrate was placed in a vacuum distillation apparatus, the methylene chloride was evaporated, and the product was purified by column chromatography using silica gel .

본 발명에 따른 포토레지스트 조성물은, 상기 화학식 1로 표시되는 용해억제제, 감광성 고분자, 광산발생제 및 유기용매를 포함하며, 필요에 따라, 반응억제제(Quencher)로서 염기성 화합물, 계면활성제 등을 더욱 포함할 수 있다.The photoresist composition according to the present invention comprises the dissolution inhibitor represented by the above-mentioned formula (1), the photosensitive polymer, the photoacid generator and the organic solvent, and further includes a basic compound, a surfactant and the like as a reaction inhibitor can do.

본 발명의 포토레지스트 조성물에 있어서, 상기 감광성 고분자의 함량은 3 내지 30 중량%, 바람직하게는 3 내지 15 중량%이다. 또한, 상기 화학식 1로 표시되는 용해억제제의 함량은, 감광성 고분자 100 중량부에 대하여 1 내지 30 중량부, 바람직하게는 2 내지 10 중량부이고, 상기 광산발생제의 함량은, 감광성 고분자 100 중량부에 대하여 0.05 내지 10 중량부이며, 상기 포토레지스트 조성물의 나머지 성분은 유기 용매이다. 또한, 반응억제제(Quencher)로서 염기성 화합물이 사용될 경우, 그 사용량은 전체 포토레지스트 조성물에 대하여, 0.01 내지 10 중량%, 바람직하게는 0.01 내지 2 중량%이다. In the photoresist composition of the present invention, the content of the photosensitive polymer is 3 to 30% by weight, preferably 3 to 15% by weight. The content of the dissolution inhibitor represented by Formula 1 is 1 to 30 parts by weight, preferably 2 to 10 parts by weight based on 100 parts by weight of the photosensitive polymer, and the content of the photoacid generator is 100 parts by weight And the remaining component of the photoresist composition is an organic solvent. When a basic compound is used as a reaction inhibitor, the amount of the basic compound used is 0.01 to 10% by weight, preferably 0.01 to 2% by weight based on the total photoresist composition.

상기 용해억제제의 함량이 너무 작으면, 노광부와 비노광부의 용해도 차이를 효과적으로 증가시킬 수 없으므로, 본 발명의 목적을 충분히 달성하기 어렵고, 상기 용해억제제의 함량이 너무 많으면, 포토레지스트의 주성분인 고분자 혼합물들의 물성을 변화시켜, 노광 시 발생되는 산이 고분자의 탈 보호반응을 방해할 우려가 있고, 이는 궁극적으로 레지스트의 해상력을 훼손한다. 또한 증가한 저분자 함량 때문에, 고분자 혼합물의 용해력 역시 증가하여, 노광 작업 후의 현상 과정에서 비노광부까지 용해될 수 우려가 있다. 상기 감광성 고분자의 함량이 너무 작으면, 원하는 두께의 레지스트막을 형성하기 어렵고, 너무 많으면, 웨이퍼 상에 형성된 패턴의 두께 분포가 고르지 못하게 될 우려가 있다. 상기 광산발생제의 사용량이 너무 적으면, 포토레지스트의 광에 대한 민감도가 저하되고, 너무 많으면, 광산발생제가 원자외선을 많이 흡수하고, 과량의 산이 생성되어, 패턴의 단면 형상이 불균일해질 우려가 있다. 그리고, 상기 염기성 화합물의 사용량이 너무 적으면, 노광 중 발생한 산의 확산 조절이 용이하지 못하여 패턴의 단면 형상이 불균일해질 수 있으며, 너무 많으면, 발생한 산의 확산을 과도하게 억제하여, 패턴의 구현이 용이하지 못하다.If the content of the dissolution inhibitor is too small, it is difficult to sufficiently attain the object of the present invention because the difference in solubility between the exposed portion and the unexposed portion can not be effectively increased. If the content of the dissolution inhibitor is too large, The physical properties of the mixtures may be changed so that the acid generated upon exposure may interfere with the deprotection reaction of the polymer, which ultimately undermines the resolving power of the resist. Furthermore, because of the increased low molecular weight content, the solubility of the polymer mixture also increases, which may lead to dissolution of the unexposed area in the development process after exposure. If the content of the photosensitive polymer is too small, it is difficult to form a resist film having a desired thickness. If the content of the photosensitive polymer is too large, the thickness distribution of the pattern formed on the wafer may become uneven. If the amount of the photoacid generator used is too small, the sensitivity of the photoresist to light is deteriorated. If the amount is too large, the photoacid generator may absorb much of the ultraviolet light and generate an excessive amount of acid, have. If the amount of the basic compound used is too small, the diffusion of the generated acid during the exposure can not be easily controlled and the cross-sectional shape of the pattern may be uneven. If too large, the diffusion of the generated acid may be excessively suppressed, It is not easy.

상기 감광성 고분자로는, 산과 반응하여 현상액에 대한 용해도가 변화하는 통상의 포토레지스트용 감광성 고분자를 제한없이 사용할 수 있으며, 바람직하게는 산에 의하여 탈리될 수 있는, 즉, 산에 민감한 보호기를 가지는 감광성 고분자를 사용할 수 있다. 상기 감광성 고분자는 블록 공중합체 또는 랜덤 공중합체일 수 있으며, 중량평균분자량(Mw)은 3,000 내지 20,000인 것이 바람직하다.As the photosensitive polymer, a conventional photosensitive polymer for a photoresist which reacts with an acid to change its solubility in a developing solution can be used without limitation, and it is preferable to use a photosensitive polymer which can be desorbed by an acid, Polymers can be used. The photosensitive polymer may be a block copolymer or a random copolymer, and preferably has a weight average molecular weight (Mw) of 3,000 to 20,000.

상기 광산발생제로는, 빛의 조사에 의해 산을 발생시키는 화합물을 제한없이 사용할 수 있으며, 포토레지스트 조성물의 광산발생제로서 통상 사용되는 오니움 염(onium salt), 예를 들면, 설포늄염계 또는 아이오도늄염계 화합물을 사용할 수 있다. 특히 프탈이미도트리 플루오로메탄술포네이트 (phthalimidotrifluoromethane sulfonate), 디니트로벤질 토실레이트 (dinitrobenzyltosylate), n-데실디술폰 (n-decyl disulfone) 및 나프틸이미도트리 플루오로메탄술포네이트 (naphthylimido trifluoromethane sulfonate)로 이루어진 군으로부터 선택되는 것을 사용할 수 있고, 또한, 디페닐요도염 트리플레이트, 디페닐요도염 노나플레이트, 디페닐요도염 헥사플루오로포스페이트, 디페닐요도염 헥사플루오로아르세네이트, 디페닐요도염 헥사플루오로안티모네이트, 디페닐파라메톡시페닐설포늄 트리플레이트, 디페닐 파라톨루에닐설포늄 트리플레이트, 디페닐파라터셔리부틸페닐설포늄 트리플레이트, 디페닐파라이소부틸 페닐설포늄 트리플레이트, 트리페닐설포늄 트리플레이트, 트리 스파라터셔리부틸 페닐설포늄 트리플레이트, 디페닐파라메톡시페닐설포늄 노나플레이트, 디페닐파라톨루에닐설포늄 노나플레이트, 디페닐파라터셔리부틸 페닐설포늄 노나플레이트, 디페닐파라이소부틸페닐설포늄 노나플레이트, 트리페닐설포늄 노나플레이트, 트리스파라터셔리부틸페닐설포늄 노나플레이트, 헥사플루오로 아르세네이트, 트리페닐설포늄 헥사플루오로안티모네이트, 트리페닐설포늄 트리플레이트 및 디부틸나프틸설포늄 트리플레이트로 이루어진 군으로부터 선택된 광산발생제를 사용할 수 있다. As the photoacid generator, a compound capable of generating an acid upon irradiation with light can be used without limitation, and an onium salt commonly used as a photoacid generator of a photoresist composition, such as a sulfonium salt or An iodonium salt-based compound can be used. In particular, it is possible to use phthalimidotrifluoromethane sulfonate, dinitrobenzyltosylate, n-decyl disulfone and naphthylimido trifluoromethane sulfonate as starting materials. And it is also possible to use those selected from the group consisting of diphenyl iodide salt triflate, diphenyl iodide salt nonaplate, diphenyl iodide salt hexafluorophosphate, diphenyl iodide salt hexafluoroarsenate, diphenyl iodide salt hexafluoroantimo Tetraphenylsulfonium triflate, diphenyl para-methoxyphenylsulfonium triflate, diphenyl para-toluenesulfonium triflate, diphenyl para-tertiary butylphenylsulfonium triflate, diphenyl paraisobutylphenyl sulfonium triflate, triphenylsulfonium triflate, Triflate, triflate, tetrabutylphenylsulfonium triflate, di Diphenyl para-toluenesulfonium nonaplate, diphenyl para-tert-butylphenylsulfonium nonaplate, diphenyl paraisobutylphenylsulfonium nonaplate, triphenylsulfonium nonaplate, A photoacid generator selected from the group consisting of triarylsulfuric anhydride, triarylsulfuric anhydride, triarylsulfuric anhydride, triarylsulfuric anhydride, triarylsulfuric anhydride, triarylsulfuric anhydride, triarylsulfuric anhydride, triarylsulfuric anhydride, Can be used.

상기 유기용매로는, 포토레지스트 조성물의 용매로서 통상 사용되는 유기용매를 제한없이 사용할 수 있으며, 예를 들면, 에틸렌글리콜모노메틸에틸, 에틸렌글리콜 모노에틸에테르, 에틸렌글리콜모노메틸에테르, 에틸렌글리콜 모노아세테이트, 디에틸렌글리콜, 디에틸렌글리콜모노에틸에테르, 프로필렌글리콜 모노메틸에테르 아세테이트(PGMEA), 프로필렌글리콜, 프로필렌글리콜 모노아세테이트, 톨루엔, 자일렌, 메틸에틸케톤, 메틸이소아밀케톤, 시클로헥산온, 디옥산, 메틸락테이트, 에틸락테이트, 메틸피루베이트, 에틸피루베이트, 메틸메톡시프로피오네이트, 에틸에톡시 프로피오네이트, N,N-디메틸포름아마이드, N,N-디메틸아세트아마이드, N-메틸 2-피롤리돈, 3-에톡시에틸프로피오네이트, 2-헵탄온, 감마-부티로락톤, 2-히드록시프로피온에틸, 2-히드록시 2-메틸프로피온산에틸, 에톡시초산에틸, 히드록시초산에틸, 2-히드록시 3-메틸부탄산메틸, 3-메톡시 2-메틸프로피온산메틸, 3-에톡시프로피온산에틸, 3-메톡시 2-메틸프로피온산에틸, 초산에틸, 초산부틸, 이들의 혼합물 등을 사용할 수 있다. As the organic solvent, an organic solvent usually used as a solvent for a photoresist composition may be used without limitation. Examples of the organic solvent include ethylene glycol monomethyl ethyl, ethylene glycol monoethyl ether, ethylene glycol monomethyl ether, ethylene glycol monoacetate , Diethylene glycol, diethylene glycol monoethyl ether, propylene glycol monomethyl ether acetate (PGMEA), propylene glycol, propylene glycol monoacetate, toluene, xylene, methyl ethyl ketone, methyl isoamyl ketone, cyclohexanone, di N-dimethylacetamide, N, N-dimethylacetamide, N, N-dimethylacetamide, N, N-dimethylacetamide, N-methylpyrrolidone, N-methylpyrrolidone, Methyl 2-pyrrolidone, 3-ethoxyethyl propionate, 2-heptanone, gamma-butyrolactone, 2-hydroxypropionyl ethyl, 2- Ethoxyacetate, ethyl hydroxyacetate, methyl 2-hydroxy-3-methylbutanoate, methyl 3-methoxy-2-methylpropionate, ethyl 3-ethoxypropionate, 3-methoxy 2 Ethyl ethyl ketone, ethyl acetate, ethyl acetate, butyl acetate, and mixtures thereof.

또한, 상기 반응억제제(Quencher)로 사용되는 염기성 화합물로는, 트리에틸아민, 트리이소부틸아민, 트리옥틸아민, 트리이소옥틸아민, 디에탄올아민, 트리에탄올아민, 이들의 혼합물 등을 예시할 수 있다. 상기 언급된 광산발생제(PAG), 용매, 염기 이외에도, 범용의 광산발생제, 용매, 염기를 사용할 수 있음은 자명하다. 본 발명에 따른 포토레지스트 조성물에, 필요에 따라 포함되는 계면활성제는, 포토레지스트 조성물 성분의 균일 혼합성, 포토레지스트 조성물의 도포성, 포토레지스트막의 노광 후 현상성 등을 개선하는 용도로 첨가된다. 이와 같은 계면활성제로서는, 포토레지스트 조성물에 사용되는 통상적인 계면활성제가 제한없이 사용될 수 있으며, 예를 들면, 불소계 계면활성제나, 불소-규소계 계면활성제 등이 사용될 수 있다. 상기 계면활성제의 사용량은, 포토레지스트 조성물의 고형분 100 중량부에 대하여 0.001 내지 2 중량부, 바람직하게는 0.01 내지 1 중량부이며, 그 사용량이 너무 적으면 계면활성제로서의 기능을 충분히 발현할 수 없는 경우가 있고, 너무 많으면 형상 안정성이나 조성물의 보존 안정성 등 도포성 이외의 레지스트 특성에 악영향을 미치는 경우가 있다. Examples of the basic compound used as the quencher include triethylamine, triisobutylamine, trioctylamine, triisooctylamine, diethanolamine, triethanolamine, mixtures thereof, and the like . In addition to the above-mentioned photoacid generators (PAG), solvent, and base, it is obvious that a general photoacid generator, a solvent, and a base can be used. The surfactant contained in the photoresist composition according to the present invention, if necessary, is added to improve the homogeneous mixing property of the photoresist composition component, the coating property of the photoresist composition, and the post-exposure developability of the photoresist composition. As such a surfactant, a conventional surfactant used in a photoresist composition may be used without limitation. For example, a fluorine-based surfactant, a fluorine-silicon-based surfactant, and the like may be used. The amount of the surfactant to be used is 0.001 to 2 parts by weight, preferably 0.01 to 1 part by weight, based on 100 parts by weight of the solid content of the photoresist composition. When the amount of the surfactant is too small, , And if it is too large, the resist properties other than the coating properties such as shape stability and storage stability of the composition may be adversely affected.

본 발명의 포토레지스트 조성물을 이용하여, 포토레지스트 패턴을 형성하기 위해서는, (i) 먼저, 실리콘 웨이퍼, 알루미늄 기판 등의 기판 상부에, 스핀 코터 등을 이용하여, 상기 포토레지스트 조성물을 도포하여, 포토레지스트막을 형성하 고, (ii) 상기 포토레지스트막을 소정 패턴으로 노광한 다음, (iii) 노광된 포토레지스트막을 가열(bake) 및 현상한다. 상기 현상 공정에 사용되는 현상액으로는 수산화나트륨, 수산화칼륨, 탄산나트륨, 테트라메틸암모늄히드록 사이드(TMAH) 등의 알칼리성 화합물을 0.1 내지 10 중량%의 농도로 용해시킨 알칼리 수용액을 사용할 수 있으며, 상기 현상액에는 메탄올, 에탄올 등과 같은 수용성 유기용매 및 계면활성제를 적정량 첨가할 수 있다. In order to form a photoresist pattern using the photoresist composition of the present invention, (i) first, the photoresist composition is applied onto a substrate such as a silicon wafer or an aluminum substrate using a spin coater or the like, Forming a resist film, (ii) exposing the photoresist film to a predetermined pattern, and (iii) baking and developing the exposed photoresist film. The developing solution used in the developing step may be an aqueous alkaline solution obtained by dissolving an alkaline compound such as sodium hydroxide, potassium hydroxide, sodium carbonate, tetramethylammonium hydroxide (TMAH) in a concentration of 0.1 to 10 wt% An appropriate amount of a water-soluble organic solvent such as methanol, ethanol and the like and a surfactant may be added.

이하, 구체적인 실시예를 통하여 본 발명을 더욱 상세히 설명한다. 하기 실시예는 본 발명을 예시하기 위한 것으로서, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to specific examples. The following examples illustrate the present invention and are not intended to limit the scope of the present invention.

[제조예 1-1] 화학식 3a로 표시되는 화합물의 제조 [Preparation Example 1-1] Preparation of the compound represented by the formula (3a)

하기 반응식 2에 나타낸 바와 같이, 질소 조건에서 화학식 2a로 표시되는 헥사메틸렌디이소시아네이트(1,6-Hexamethylene diisocyanate) 50g(295.7 mmol)과 2-메틸-2-아다만타놀(2-methyl-2-adamantanol) 50g(300.7 mmol)을 n-메틸피롤리덴 (NMP, N-methylpyrrolidine)에 용해시킨 후, 115℃에서 n-부틸아민 (n-butylamine)을 첨가하고, 6시간 동안 반응시켰다. 반응종료 후, 메탄올(methanol)로 세척하고, 메틸렌클로라이드(methylenechloride)로 추출하고 분리한 다음, 무수 마그네슘 설페이트(anhydrous magnesium sulfate)에 여과시켰다. 그 여액을 감압증류기에 넣고, 메틸렌클로라이드를 증발시킨 후, 실리카겔을 이용한 컬럼 크로마토그래피( 전개용매, 헥산 : 에틸 아세테이트(EA) = 1 : 1)를 통해서 생성물을 분리하여, 흰색의 고체인 화학식 3a로 표시되는 화합물을 얻었다{수율: 72.5%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH,1H), 3.31(CH2, 2H), 2.96(CH2, 2H), 2.29(H, 2H), 1.77(H, 2H), 1.56(H, 1H), 1.55(CH2, 2H), 1.52(H, 1H), 1.50(CH3, 3H), 1.40(H, 1H), 1.36(CH2, 2H), 1.31(H, 1H), 1.30(CH2, 2H), 1.29(CH2, 4H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.As shown in the following Reaction Scheme 2, 50 g (295.7 mmol) of 1,6-hexamethylene diisocyanate and 2-methyl-2- adamantanol) was dissolved in N-methylpyrrolidine (NMP), n-butylamine was added at 115 ° C, and the reaction was carried out for 6 hours. After completion of the reaction, the reaction mixture was washed with methanol, extracted with methylenechloride, separated, and then filtered through anhydrous magnesium sulfate. The filtrate was put in a vacuum distillation apparatus and the methylene chloride was evaporated. The product was isolated by column chromatography using silica gel (developing solvent, hexane: ethyl acetate (EA) = 1: 1) to obtain a compound represented by {yield: 72.5%, 1 H-NMR (CDCl 3, internal standard): δ (ppm) 8.00 ( NH, 1H), 3.31 (CH 2, 2H), 2.96 (CH 2, 2H ), 2.29 (H, 2H) , 1.77 (H, 2H), 1.56 (H, 1H), 1.55 (CH 2, 2H), 1.52 (H, 1H), 1.50 (CH 3, 3H), 1.40 (H, 1H), 1.36 (CH 2, 2H), 1.31 (H, 1H), 1.30 (CH 2, 2H), 1.29 (CH 2, 4H), 1.18 (H, 1H), 1.14 (H, 1H), 0.65 ( H, 2H).

Figure 112008025914823-pat00030
Figure 112008025914823-pat00030

[화학식 3a][Chemical Formula 3]

Figure 112008025914823-pat00031
Figure 112008025914823-pat00031

[제조예 1-2] 화학식 3b로 표시되는 화합물의 제조 [Preparation Example 1-2] Preparation of the compound represented by the formula (3b)

상기 화학식 2a로 표시되는 화합물 50g 대신, 화학식 2b로 표시되는 화합물 50g(300.9mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 3b로 표시되는 화합물을 얻었다{수율: 81.7%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 1H), 3.54(CH, 1H), 3.22(CH, 1H), 2.29(H, 2H), 1.77(H, 2H), 1.66(CH2, 4H), 1.50(CH3, 3H), 1.40(CH2, 4H), 1.36(CH2, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.40(H, 1H), 1.31(H, 1H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.The compound represented by Formula 3b was obtained in the same manner as in Preparation Example 1-1 except that 50 g (300.9 mmol) of the compound represented by Formula 2b was used instead of 50 g of the compound represented by Formula 2 ({Yield: 81.7% , 1 H-NMR (CDCl 3 , internal standard): δ (ppm) 8.00 ( NH, 1H), 3.54 (CH, 1H), 3.22 (CH, 1H), 2.29 (H, 2H), 1.77 (H, 2H), 1.66 (CH 2, 4H), 1.50 (CH 3, 3H), 1.40 (CH 2, 4H), 1.36 (CH 2, 2H), 1.56 (H, 1H), 1.52 (H, 1H), 1.40 (H, IH), 1.31 (H, IH), 1.18 (H, IH), 1.14

[화학식 3b](3b)

Figure 112008025914823-pat00032
Figure 112008025914823-pat00032

[제조예 1-3] 화학식 3c로 표시되는 화합물의 제조 [Preparation Example 1-3] Preparation of the compound represented by the formula (3c)

상기 화학식 2a로 표시되는 화합물 50g 대신, 화학식 2c로 표시되는 화합물 50g(190.6mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 3c로 표시되는 화합물을 얻었다{수율: 78.3%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 1H), 3.54(CH, 1H), 3.22(CH, 1H), 1.66(CH2, 4H), 1.50(CH3, 3H), 1.43(CH, 2H), 1.40(CH2, 12H), 1.36(CH2, 2H), 2.29(H, 2H), 1.77(H, 2H), 1.40(CH2, 4H), 1.36(CH2, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.40(H, 1H), 1.31(H, 1H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.The compound represented by Formula 3c was obtained in the same manner as in Preparation Example 1-1 except that 50 g (190.6 mmol) of the compound represented by Formula 2c was used instead of 50 g of the compound represented by Formula 2a (yield: 78.3% , 1 H-NMR (CDCl 3 , internal standard): δ (ppm) 8.00 ( NH, 1H), 3.54 (CH, 1H), 3.22 (CH, 1H), 1.66 (CH 2, 4H), 1.50 (CH 3, 3H), 1.43 (CH , 2H), 1.40 (CH 2, 12H), 1.36 (CH 2, 2H), 2.29 (H, 2H), 1.77 (H, 2H), 1.40 (CH 2, 4H), 1.36 (CH 2, 2H), 1.56 (H, 1H), 1.52 (H, 1H), 1.40 (H, 1H), 1.31 (H, 1H), 1.18 (H, 1H), 1.14 (H, 1H), 0.65 (H, 2H).

[화학식 3c][Chemical Formula 3c]

Figure 112008025914823-pat00033
Figure 112008025914823-pat00033

[제조예 1-4] 화학식 3d로 표시되는 화합물의 제조 [Preparation Example 1-4] Preparation of the compound represented by the general formula (3d)

상기 화학식 2a로 표시되는 화합물 50g 대신, 화학식 2d로 표시되는 화합물 50g(225.1mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 3d로 표시되는 화합물을 얻었다{수율: 76.3%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 1H), 3.22(CH, 1H), 2.88(CH2, 2H), 2.29(H, 2H), 1.50(CH3, 3H), 1.40(CH2, 4H), 1.36(CH2, 2H), 1.28(CH2, 2H), 1.16(CH3, 3H), 1.11(CH3, 6H), 1.77(H, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.40(H, 1H), 1.31(H, 1H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.The compound represented by Formula (3d) was obtained in the same manner as in Preparation Example 1-1, except that 50 g (225.1 mmol) of the compound represented by Formula (2d) was used instead of 50 g of the compound represented by Formula (2a) {Yield: 76.3% , 1 H-NMR (CDCl 3 , internal standard): δ (ppm) 8.00 ( NH, 1H), 3.22 (CH, 1H), 2.88 (CH 2, 2H), 2.29 (H, 2H), 1.50 (CH 3, 3H), 1.40 (CH 2, 4H), 1.36 (CH 2, 2H), 1.28 (CH 2, 2H), 1.16 (CH 3, 3H), 1.11 (CH 3, 6H), 1.77 (H, 2H ), 1.56 (H, IH), 1.52 (H, IH), 1.40 (H, IH), 1.31 (H, }.

[화학식 3d](3d)

Figure 112008025914823-pat00034
Figure 112008025914823-pat00034

[제조예 1-5] 화학식 3e로 표시되는 화합물의 제조 [Preparation Example 1-5] Preparation of a compound represented by the formula (3e)

상기 화학식 2a로 표시되는 화합물 50g 대신, 화학식 2e로 표시되는 화합물 50g(105.8mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 3e로 표시되는 화합물을 얻었다{수율: 71.3%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 1H), 7.05(H, 1H), 5.25(CH2, 4H), 4.98(H, 1H), 3.31(CH2, 2H), 2.29(H, 2H), 1.77(H, 2H), 1.52(CH, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.50(CH3, 3H), 1.40(H, 1H), 1.36(CH2, 2H), 1.33(CH2, 4H), 1.31(H, 1H), 1.30(CH2, 2H), 1.29(CH2, 20H), 1.25(CH2, 6H), 0.96(CH3, 6H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.Compound (3e) was obtained in the same manner as in Preparation Example 1-1 except that 50g (105.8mmol) of the compound represented by Formula (2e) was used instead of 50g of the compound represented by Formula (2a) {Yield: 71.3% , 1 H-NMR (CDCl 3 , internal standard): δ (ppm) 8.00 ( NH, 1H), 7.05 (H, 1H), 5.25 (CH 2, 4H), 4.98 (H, 1H), 3.31 (CH 2, 2H), 2.29 (H , 2H), 1.77 (H, 2H), 1.52 (CH, 2H), 1.56 (H, 1H), 1.52 (H, 1H), 1.50 (CH 3, 3H), 1.40 ( H, 1H), 1.36 (CH 2, 2H), 1.33 (CH 2, 4H), 1.31 (H, 1H), 1.30 (CH 2, 2H), 1.29 (CH 2, 20H), 1.25 (CH 2, 6H ), 0.96 (CH 3, 6H ), 1.18 (H, 1H), 1.14 (H, 1H), 0.65 (H, 2H)}.

[화학식 3e][Formula 3e]

Figure 112008025914823-pat00035
Figure 112008025914823-pat00035

[제조예 1-6] 화학식 3f로 표시되는 화합물의 제조 [Preparation Example 1-6] Preparation of the compound represented by the formula (3f)

상기 화학식 2a로 표시되는 화합물 50g 대신, 화학식 2f로 표시되는 화합물 50g(160.2mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 3f로 표시되는 화합물을 얻었다 {수율: 82.6%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 1H), 3.63(H, 2H), 3.28(H, 2H), 2.29(H, 2H), 1.77(H, 2H) 1.56(H, 1H), 1.52(H, 1H), 1.50(CH3, 3H), 1.40(H, 1H), 1.36(CH2, 2H), 1.31(H, 1H),1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.Compound (3f) was obtained in the same manner as in Preparation Example 1-1 except that 50g (160.2mmol) of the compound represented by Formula (2f) was used instead of 50g of the compound represented by Formula (2a) {Yield: 82.6% , 1 H-NMR (CDCl 3 , internal standard): δ (ppm) 8.00 ( NH, 1H), 3.63 (H, 2H), 3.28 (H, 2H), 2.29 (H, 2H), 1.77 (H, 2H) 1.56 (H, 1H) , 1.52 (H, 1H), 1.50 (CH 3, 3H), 1.40 (H, 1H), 1.36 (CH 2, 2H), 1.31 (H, 1H), 1.18 (H, 1H), 1.14 (H, 1 H), 0.65 (H, 2H)}.

[화학식 3f](3f)

Figure 112008025914823-pat00036
Figure 112008025914823-pat00036

[실시예 1-1] 화학식 1a로 표시되는 용해억제제의 제조 [Example 1-1] Preparation of dissolution inhibitor represented by formula (Ia)

하기 반응식 3에 나타낸 바와 같이, 화학식 3a로 표시되는 화합물 50g(149.5mmol)과 녹말(starch) 50g(260.1mmol)을 n-메틸피롤리덴에 용해시킨 후, 115℃에서 n-부틸아민을 첨가하고, 4시간 동안 반응시켰다. 반응종료 후, 메탄올로 세척하고, 메틸렌클로라이드로 추출하고 분리한 다음, 무수 마그네슘 설페이트에 여과시켰다. 그 여액을 감압증류기에 넣고, 메틸렌클로라이드를 증발시킨 후, 실리카겔을 이용한 컬럼 크로마토그래피(전개용매, 헥산 : 에틸 아세테이트(EA) = 1 : 1)를 통해서 생성물을 분리하여, 흰색의 고체인 용해억제제(화학식 1a)를 얻었다{수율: 53.7%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 2H), 4.51(CH, 1H), 4.21(CH2, 2H), 3.85(CH, 1H), 3.73(CH, 1H), 3.40(CH, 1H), 3.24(CH3, 3H), 3.02(CH, 2H), 2.96(CH2, 4H), 2.00(OH, 2H), 1.55(CH2, 4H), 1.50(CH3, 3H), 1.36(CH2, 2H), 1.29(CH2, 4H), 1.21(CH3, 3H), 2.29(H, 2H), 1.77(H, 2H), 1.56(H, 1H), 1.55(CH2, 2H), 1.52(H, 1H), 1.40(H, 1H), 1.36(CH2, 2H), 1.31(H, 1H), 1.30(CH2, 2H), 1.29(CH2, 4H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.As shown in Scheme 3, 50 g (149.5 mmol) of the compound represented by the general formula (3a) and 50 g (260.1 mmol) of starch were dissolved in n-methylpyrrolidone, and then n-butylamine And reacted for 4 hours. After completion of the reaction, the reaction solution was washed with methanol, extracted with methylene chloride, separated, and then filtered through anhydrous magnesium sulfate. The filtrate was put in a vacuum distillation apparatus and the methylene chloride was evaporated. The product was isolated by column chromatography using silica gel (developing solvent, hexane: ethyl acetate (EA) = 1: 1) to obtain a white solid dissolution inhibitor to give the compound (formula 1a) {yield: 53.7%, 1 H-NMR (CDCl 3, internal standard): δ (ppm) 8.00 ( NH, 2H), 4.51 (CH, 1H), 4.21 (CH 2, 2H) , 3.85 (CH, 1H), 3.73 (CH, 1H), 3.40 (CH, 1H), 3.24 (CH 3, 3H), 3.02 (CH, 2H), 2.96 (CH 2, 4H), 2.00 (OH, 2H ), 1.55 (CH 2, 4H ), 1.50 (CH 3, 3H), 1.36 (CH 2, 2H), 1.29 (CH 2, 4H), 1.21 (CH 3, 3H), 2.29 (H, 2H), 1.77 (H, 2H), 1.56 ( H, 1H), 1.55 (CH 2, 2H), 1.52 (H, 1H), 1.40 (H, 1H), 1.36 (CH 2, 2H), 1.31 (H, 1H), 1.30 (CH 2, 2H), 1.29 (CH 2, 4H), 1.18 (H, 1H), 1.14 (H, 1H), 0.65 (H, 2H)}.

Figure 112008025914823-pat00037
Figure 112008025914823-pat00037

[화학식 1a][Formula 1a]

Figure 112008025914823-pat00038
Figure 112008025914823-pat00038

[실시예 1-2] 화학식 1b로 표시되는 용해억제제의 제조 [Example 1-2] Preparation of dissolution inhibitor represented by formula (1b)

상기 화학식 3a로 표시되는 화합물 50g 대신, 화학식 3b로 표시되는 화합물 50g(150.9mmol)을 사용한 것을 제외하고는, 실시예 1-1과 같은 방법으로 화학식 1b로 표시되는 용해억제제를 얻었다 {수율: 63.4%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 2H), 4.51(CH, 1H), 4.21(CH2, 2H), 3.85(CH, 1H), 3.73(CH, 1H), 3.54(CH, 2H), 3.40(CH, 1H), 3.24(CH3, 3H), 3.02(CH, 2H), 2.00(OH, 2H), 1.50(CH3, 3H), 1.36(CH2, 2H), 1.21(CH3, 3H), 2.29(H, 2H), 1.77(H, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.40(H, 1H), 1.31(H, 1H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.The dissolution inhibitor represented by the general formula (1b) was obtained in the same manner as in Example 1-1 except that 50 g (150.9 mmol) of the compound represented by the general formula (3b) was used instead of the compound represented by the general formula (3a) %, 1 H-NMR (CDCl 3, internal standard): δ (ppm) 8.00 ( NH, 2H), 4.51 (CH, 1H), 4.21 (CH 2, 2H), 3.85 (CH, 1H), 3.73 ( CH, 1H), 3.54 (CH , 2H), 3.40 (CH, 1H), 3.24 (CH 3, 3H), 3.02 (CH, 2H), 2.00 (OH, 2H), 1.50 (CH 3, 3H), 1.36 (CH 2, 2H), 1.21 (CH 3, 3H), 2.29 (H, 2H), 1.77 (H, 2H), 1.56 (H, 1H), 1.52 (H, 1H), 1.40 (H, 1H), 1.31 (H, 1 H), 1.18 (H, 1 H), 1.14 (H, 1 H), 0.65 (H, 2H)}.

[화학식 1b][Chemical Formula 1b]

Figure 112008025914823-pat00039
Figure 112008025914823-pat00039

[실시예 1-3] 화학식 1c로 표시되는 용해억제제의 제조 [Example 1-3] Preparation of dissolution inhibitor represented by formula (1c)

상기 화학식 3a로 표시되는 화합물 50g 대신, 화학식 3c로 표시되는 화합물 50g(166.9mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 1c로 표시되는 용해억제제를 얻었다 {수율: 62.1%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 2H), 4.51(CH, 1H), 4.21(CH2, 2H), 3.85(CH, 1H), 3.73(CH, 1H), 3.54(CH, 2H), 3.40(CH, 1H), 3.24(CH3, 3H), 3.02(CH, 1H), 2.00(OH, 2H), 1.66(CH2, 8H), 1.50(CH3, 3H), 1.43(CH, 1H), 1.40(CH2, 8H), 1.36(CH2, 2H), 1.21(CH3, 3H), 1.21(CH, 2H), 1.16(CH3, 3H), 1.11(CH3, 6H), 2.29(H, 2H), 1.77(H, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.40(H, 1H), 1.31(H, 1H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.A dissolution inhibitor represented by the formula (1c) was obtained in the same manner as in Preparation Example 1-1, except that 50 g (166.9 mmol) of the compound represented by the formula (3c) was used instead of 50 g of the compound represented by the above formula (3a) {Yield: 62.1 %, 1 H-NMR (CDCl 3, internal standard): δ (ppm) 8.00 ( NH, 2H), 4.51 (CH, 1H), 4.21 (CH 2, 2H), 3.85 (CH, 1H), 3.73 ( 2H), 1.66 (CH 2 , 8H), 1.50 (CH 3 , 3H), 3.04 (CH 3, 3H), 1.43 (CH, 1H), 1.40 (CH 2, 8H), 1.36 (CH 2, 2H), 1.21 (CH 3, 3H), 1.21 (CH, 2H), 1.16 (CH 3, 3H), 1.11 (CH 3, 6H), 2.29 (H, 2H), 1.77 (H, 2H), 1.56 (H, 1H), 1.52 (H, 1H), 1.40 (H, 1H), 1.31 (H, 1H), 1.18 (H, 1 H), 1.14 (H, 1 H), 0.65 (H, 2H)}.

[화학식 1c][Chemical Formula 1c]

Figure 112008025914823-pat00040
Figure 112008025914823-pat00040

[실시예 1-4] 화학식 1d로 표시되는 용해억제제의 제조 [Example 1-4] Preparation of dissolution inhibitor represented by formula (1d)

상기 화학식 3a로 표시되는 화합물 50g 대신, 화학식 3d로 표시되는 화합물 50g(129.1mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 1d로 표시되는 용해억제제를 얻었다 {수율: 56.1%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 2H), 4.51(CH, 1H), 4.21(CH2, 2H), 3.85(CH, 1H), 3.73(CH, 1H), 3.54(CH, 2H), 3.40(CH, 1H), 3.24(CH3, 3H), 3.02(CH, 1H), 3.02(CH, 2H), 2.00(OH, 2H), 1.58(CH2, 4H), 1.50(CH3, 3H), 1.36(CH2, 2H), 1.28(CH2, 2H), 1.21(CH3, 3H), 1.16(CH3, 3H), 1.11(CH3, 6H), 2.29(H, 2H), 1.77(H, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.40(H, 1H), 1.31(H, 1H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.A dissolution inhibitor represented by the formula (1d) was obtained in the same manner as in Preparation Example 1-1 except that 50 g (129.1 mmol) of the compound represented by the formula (3) was used in place of the compound (3) represented by the formula (3a) {Yield: 56.1 %, 1 H-NMR (CDCl 3, internal standard): δ (ppm) 8.00 ( NH, 2H), 4.51 (CH, 1H), 4.21 (CH 2, 2H), 3.85 (CH, 1H), 3.73 ( CH, 1H), 3.54 (CH , 2H), 3.40 (CH, 1H), 3.24 (CH 3, 3H), 3.02 (CH, 1H), 3.02 (CH, 2H), 2.00 (OH, 2H), 1.58 ( CH 2, 4H), 1.50 ( CH 3, 3H), 1.36 (CH 2, 2H), 1.28 (CH 2, 2H), 1.21 (CH 3, 3H), 1.16 (CH 3, 3H), 1.11 (CH 3 1H, 1H), 1.18 (2H, m), 2.32 (2H, 1H), 1.14 (H, 1 H), 0.65 (H, 2H)}.

[화학식 1d]≪ RTI ID = 0.0 &

Figure 112008025914823-pat00041
Figure 112008025914823-pat00041

[실시예 1-5] 화학식 1e로 표시되는 용해억제제의 제조 [Example 1-5] Preparation of dissolution inhibitor represented by the formula (1e)

상기 화학식 3a로 표시되는 화합물 50g 대신, 화학식 3e로 표시되는 화합물 50g(78.4mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 1e로 표시되는 용해억제제를 얻었다 {수율: 49.6%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 2H), 5.25(CH2, 2H), 4.98(H, 1H), 4.51(CH, 1H), 4.21(CH2, 2H), 3.85(CH, 1H), 3.73(CH, 1H), 3.40(CH, 1H), 3.24(CH3, 3H), 3.02(CH, 2H), 2.96(CH2, 2H), 2.00(OH, 2H), 1.55(CH2, 4H), 1.52(CH, 2H), 1.50(CH3, 3H), 1.47(CH2, 4H), 1.36(CH2, 2H), 1.33(CH2, 4H), 1.29(CH2, 20H), 1.25(CH2, 6H), 1.21(CH3, 3H), 1.16(CH3, 3H), 1.11(CH3, 6H), 2.29(H, 2H), 1.77(H, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.40(H, 1H), 1.31(H, 1H), 1.18(H, 1H), 1.14(H, 1H), 0.96(CH3, 6H), 0.65(H, 2H)}.A dissolution inhibitor represented by the formula (1e) was obtained in the same manner as in Preparation Example 1-1 except that 50 g (78.4 mmol) of the compound represented by the formula (3e) was used instead of the compound represented by the formula (3a) %, 1 H-NMR (CDCl 3, internal standard): δ (ppm) 8.00 ( NH, 2H), 5.25 (CH 2, 2H), 4.98 (H, 1H), 4.51 (CH, 1H), 4.21 ( CH 2, 2H), 3.85 ( CH, 1H), 3.73 (CH, 1H), 3.40 (CH, 1H), 3.24 (CH 3, 3H), 3.02 (CH, 2H), 2.96 (CH 2, 2H), 2.00 (OH, 2H), 1.55 (CH 2, 4H), 1.52 (CH, 2H), 1.50 (CH 3, 3H), 1.47 (CH 2, 4H), 1.36 (CH 2, 2H), 1.33 (CH 2 , 4H), 1.29 (CH 2 , 20H), 1.25 (CH 2, 6H), 1.21 (CH 3, 3H), 1.16 (CH 3, 3H), 1.11 (CH 3, 6H), 2.29 (H, 2H) (H, IH), 1.34 (H, IH), 1.77 (H, 0.96 (CH 3, 6H), 0.65 (H, 2H)}.

[화학식 1e][Formula 1e]

Figure 112008025914823-pat00042
Figure 112008025914823-pat00042

[실시예 1-6] 화학식 1f로 표시되는 용해억제제의 제조 [Example 1-6] Preparation of the dissolution inhibitor represented by the formula (1f)

상기 화학식 3a로 표시되는 화합물 50g 대신, 화학식 3f로 표시되는 화합물 50g(78.4mmol)을 사용한 것을 제외하고는, 제조예 1-1과 같은 방법으로 화학식 1f로 표시되는 용해억제제를 얻었다 {수율: 49.6%, 1H-NMR(CDCl3, 내부표준물질): δ(ppm) 8.00(NH, 2H), 4.51(CH, 1H), 4.21(CH2, 2H), 3.85(CH, 1H), 3.73(CH, 1H), 3.40(CH, 1H), 3.28(H, 4H), 3.24(CH3, 3H), 3.02(CH, 1H), 2.00(OH, 2H), 1.50(CH3, 3H), 1.36(CH2, 2H), 1.21(CH3, 3H), 2.29(H, 2H), 1.77(H, 2H), 1.56(H, 1H), 1.52(H, 1H), 1.40(H, 1H), 1.31(H, 1H), 1.18(H, 1H), 1.14(H, 1H), 0.65(H, 2H)}.The dissolution inhibitor represented by the formula (1f) was obtained in the same manner as in Preparation Example 1-1 except that 50g (78.4mmol) of the compound represented by the formula (3f) was used instead of 50g of the compound represented by the above formula (3a) {Yield: 49.6 %, 1 H-NMR (CDCl 3, internal standard): δ (ppm) 8.00 ( NH, 2H), 4.51 (CH, 1H), 4.21 (CH 2, 2H), 3.85 (CH, 1H), 3.73 ( CH, 1H), 3.40 (CH , 1H), 3.28 (H, 4H), 3.24 (CH 3, 3H), 3.02 (CH, 1H), 2.00 (OH, 2H), 1.50 (CH 3, 3H), 1.36 (CH 2, 2H), 1.21 (CH 3, 3H), 2.29 (H, 2H), 1.77 (H, 2H), 1.56 (H, 1H), 1.52 (H, 1H), 1.40 (H, 1H), 1.31 (H, 1 H), 1.18 (H, 1 H), 1.14 (H, 1 H), 0.65 (H, 2H)}.

[화학식 1f](1f)

Figure 112008025914823-pat00043
Figure 112008025914823-pat00043

[실시예 2-1 내지 2-6] 포토레지스트 조성물 제조 및 노광 패턴 형성 [Examples 2-1 to 2-6] Photoresist composition and exposure pattern formation

상기 실시예 1-1 내지 1-6 에서 합성한 용해억제제 0.2g, 감광성 고분자 (MAdMA : GBLMA : HMA = 40 : 30 : 30, Mw=8,000, PD=1.92) 2.0g, 광산발생제로서 트리페닐설포늄 트리플레이트(triphenylsulfonium triplate) 0.08g, 반응억제제로서 트리에탄올아민(TEA, triethanolamine) 0.02g 및 유기용매로서 프로필렌글리콜 모노메틸에테르아세테이트(PGMEA, propylene glycol monomethyl ether acetate) 20g을 혼합하고, 필터로 여과하여, 각각의 포토레지스트 조성물을 제조하였다. 제조된 포토레지스트 조성물을, 실리콘 웨이퍼의 피식각층 상부에 스핀 코팅하여, 포토레지스트 박막을 형성한 다음, 130℃에서 90초 동안 프리베이킹(prebaking)하고, 개구수(Numerical Aperture) 0.85인 ArF ASML 1250 장비로 노광한 다음, 125℃에서 90초 동안 다시 베이크(PEB, Post exposure bake)하였다. 이렇게 베이크한 웨이퍼를 2.38 중량%의 테트라메틸 암모늄히드록사이드(TMAH, Tetramethylammonium hydroxide) 수용액으로 30초간 현상함으로써, 65nm 의 1 : 1 라인 및 스페이스 (L/S: line/space) 패턴을 형성하였다. 이와 같이 형성된 포토레지스트 패턴의 성능을 평가하여, 하기 표 1에 나타내었다. 하기 표 1에서, 초점 심도(포커스 마진, depth of focus, ㎛)는 공정 마진으로서, 레지스트막에 조사되는 노광량의 깊이로 정의되며, EOP는 최적의 노광량(mJ/cm2)으로서, 목표로 하는 패턴크기를 얻을 수 있는 노광량이다., 0.2 g of the dissolution inhibitor synthesized in Examples 1-1 to 1-6, 2.0 g of photosensitive polymer (MAdMA: GBLMA: HMA = 40: 30: 30, Mw = 8,000, PD = 1.92) 0.08 g of triphenylsulfonium triplate, 0.02 g of triethanolamine (TEA) as a reaction inhibitor and 20 g of propylene glycol monomethyl ether acetate (PGMEA) as an organic solvent were mixed and filtered with a filter To prepare respective photoresist compositions. The prepared photoresist composition was spin-coated on top of the etching layer of a silicon wafer to form a photoresist thin film and then prebaked at 130 캜 for 90 seconds to obtain ArF ASML 1250 having a numerical aperture of 0.85 (PEB, Post exposure bake) at 125 캜 for 90 seconds. The thus-baked wafer was developed with an aqueous solution of 2.38% by weight of tetramethylammonium hydroxide (TMAH) for 30 seconds to form a 1: 1 line and a space (L / S: line / space) pattern of 65 nm. The performance of the thus formed photoresist pattern was evaluated and shown in Table 1 below. In Table 1, the focus depth (focus margin, μm) is defined as the process margin, the depth of the exposure amount irradiated to the resist film, the EOP is the optimal exposure amount (mJ / cm 2 ) It is the amount of exposure that can obtain the pattern size.

실시예Example 최소해상력 [nm]Minimum resolution [nm] 초점심도 [um]Depth of focus [um] EOP [mJ/cm2]EOP [mJ / cm 2 ] 라인에지
러프니스[nm]
Line edge
Roughness [nm]
실시예 2-1Example 2-1 60.560.5 0.610.61 2626 3.013.01 실시예 2-2Example 2-2 61.861.8 0.640.64 2727 3.213.21 실시예 2-3Example 2-3 60.360.3 0.550.55 2323 3.073.07 실시예 2-4Examples 2-4 63.763.7 0.600.60 2929 2.982.98 실시예 2-5Example 2-5 62.962.9 0.620.62 3030 2.872.87 실시예 2-6Examples 2-6 65.465.4 0.650.65 3232 2.972.97

상기 표 1로부터, 본 발명에 따른 레지스트 조성물 및 65nm 해상도의 마스크를 이용하여 패터닝(Patterning)한 경우(실시예 2-1 내지 2-6), 66nm 이하의 해상력을 얻을 수 있으며, 통상의 포토레지스트 조성물을 사용할 경우 라인에지러프니스가 5 내지 6nm 값을 나타내지만, 본 발명에 따른 조성물을 사용할 경우, 라인에지러프니스가 2.87 내지 3.21nm의 값을 나타내어, 라인에지러프니스 특성이 현저히 개선됨을 알 수 있다. 또한, 극자외선(EUV) 노광장비를 이용하여, 마스크와 웨이퍼를 접촉시켜 노광한 결과, 본 발명의 포토레지스트 조성물을 이용하여 30nm의 동일 라인 및 스페이스 패턴을 성공적으로 형성할 수 있었다.It can be seen from Table 1 that a resolution of 66 nm or less can be obtained when patterning is performed using the resist composition according to the present invention and a mask having a resolution of 65 nm (Examples 2-1 to 2-6) When the composition is used, the line edge roughness shows a value of 5 to 6 nm. However, when the composition according to the present invention is used, the line edge roughness shows a value of 2.87 to 3.21 nm, . As a result of exposing the mask to a wafer using an extreme ultraviolet (EUV) exposure equipment, the same line and space pattern of 30 nm could be successfully formed using the photoresist composition of the present invention.

Claims (8)

하기 화학식 1로 표시되는 용해억제제.1. A dissolution inhibitor represented by the following formula (1). [화학식 1][Chemical Formula 1]
Figure 112014022815524-pat00044
Figure 112014022815524-pat00044
여기에서, R1은 C1 ~ C30의 선형, 분지형 또는 단일환형의 알킬기이고, R2는 C1 ~ C20의 분지형, 단일환형, 또는 다환형의 알킬기이다.Herein, R 1 is a linear, branched or cyclic alkyl group having 1 to 30 carbon atoms, and R 2 is a C1 to C20 branched, monocyclic or polycyclic alkyl group.
삭제delete 제1항에 있어서, 상기 R1
Figure 112008025914823-pat00045
,
Figure 112008025914823-pat00046
,
Figure 112008025914823-pat00047
,
Figure 112008025914823-pat00048
,
Figure 112008025914823-pat00049
, 및
Figure 112008025914823-pat00050
로 이루어진 군으로부터 선택되고, 상기 R2는,
Figure 112008025914823-pat00051
,
Figure 112008025914823-pat00052
,
Figure 112008025914823-pat00053
,
Figure 112008025914823-pat00054
,
Figure 112008025914823-pat00055
, 및
Figure 112008025914823-pat00056
로 이루어진 군으로부터 선택되는 것인 용해억제제. (여기서,
Figure 112008025914823-pat00057
은 연결부(connecting bond)를 나타낸다)
2. The compound of claim 1 wherein R < 1 >
Figure 112008025914823-pat00045
,
Figure 112008025914823-pat00046
,
Figure 112008025914823-pat00047
,
Figure 112008025914823-pat00048
,
Figure 112008025914823-pat00049
, And
Figure 112008025914823-pat00050
And R < 2 > is selected from the group consisting of hydrogen,
Figure 112008025914823-pat00051
,
Figure 112008025914823-pat00052
,
Figure 112008025914823-pat00053
,
Figure 112008025914823-pat00054
,
Figure 112008025914823-pat00055
, And
Figure 112008025914823-pat00056
≪ / RTI > (here,
Figure 112008025914823-pat00057
Represents a connecting bond)
제1항에 있어서, 상기 용해억제제는 하기 화학식 1a 내지 1f로 표시되는 군으로부터 선택되는 것인 용해억제제. The dissolution inhibitor according to claim 1, wherein the dissolution inhibitor is selected from the group consisting of the following formulas (1a) to (1f). [화학식 1a][Formula 1a]
Figure 112008025914823-pat00058
Figure 112008025914823-pat00058
[화학식 1b][Chemical Formula 1b]
Figure 112008025914823-pat00059
Figure 112008025914823-pat00059
[화학식 1c][Chemical Formula 1c]
Figure 112008025914823-pat00060
Figure 112008025914823-pat00060
[화학식 1d]≪ RTI ID = 0.0 &
Figure 112008025914823-pat00061
Figure 112008025914823-pat00061
[화학식 1e][Formula 1e]
Figure 112008025914823-pat00062
Figure 112008025914823-pat00062
[화학식 1f](1f)
Figure 112008025914823-pat00063
Figure 112008025914823-pat00063
감광성 고분자 3 내지 30 중량%;3 to 30% by weight of a photosensitive polymer; 상기 감광성 고분자 100 중량부에 대하여 1 내지 30 중량부의 하기 화학식 1로 표시되는 용해억제제,1 to 30 parts by weight of a dissolution inhibitor represented by the following general formula (1) based on 100 parts by weight of the photosensitive polymer, [화학식 1][Chemical Formula 1]
Figure 112014088818822-pat00064
Figure 112014088818822-pat00064
상기 화학식 1에서, R1은 C1 ~ C30의 선형, 분지형 또는 단일환형의 알킬기이고, R2는 C1 ~ C20의 분지형, 단일환형, 또는 다환형의 알킬기이다;Wherein R 1 is a linear, branched or cyclic alkyl group having 1 to 30 carbon atoms and R 2 is a branched or cyclic alkyl group having 1 to 20 carbon atoms; 상기 감광성 고분자 100 중량부에 대하여 0.05 내지 10 중량부의 광산발생제;0.05 to 10 parts by weight of a photoacid generator based on 100 parts by weight of the photosensitive polymer; 전체 포토레지스트 조성물에 대하여, 0.01 내지 10 중량%의 염기성 화합물; 및0.01 to 10% by weight, relative to the total photoresist composition, of a basic compound; And 나머지 유기용매로 이루어진 포토레지스트 조성물.And the remaining organic solvent.
제5항에 있어서, 상기 감광성 고분자는 산에 의하여 탈리되는 산에 민감한 보호기를 가지는 것인 포토레지스트 조성물. The photoresist composition according to claim 5, wherein the photosensitive polymer has an acid-sensitive protecting group which is cleaved by an acid. 감광성 고분자 3 내지 30 중량%;3 to 30% by weight of a photosensitive polymer; 상기 감광성 고분자 100 중량부에 대하여 1 내지 30 중량부의 하기 화학식 1로 표시되는 용해억제제,1 to 30 parts by weight of a dissolution inhibitor represented by the following general formula (1) based on 100 parts by weight of the photosensitive polymer, [화학식 1][Chemical Formula 1]
Figure 112014022815524-pat00066
Figure 112014022815524-pat00066
상기 화학식 1에서, R1은 C1 ~ C30의 선형, 분지형 또는 단일환형의 알킬기이고, R2는 C1 ~ C20의 분지형, 단일환형, 또는 다환형의 알킬기이다;Wherein R 1 is a linear, branched or cyclic alkyl group having 1 to 30 carbon atoms and R 2 is a branched or cyclic alkyl group having 1 to 20 carbon atoms; 상기 감광성 고분자 100 중량부에 대하여 0.05 내지 10 중량부의 광산발생제; 0.05 to 10 parts by weight of a photoacid generator based on 100 parts by weight of the photosensitive polymer; 전체 포토레지스트 조성물에 대하여, 0.01 내지 10 중량%의 염기성 화합물;0.01 to 10% by weight, relative to the total photoresist composition, of a basic compound; 포토레지스트 조성물의 고형분 100 중량부에 대하여 0.001 내지 2 중량부의 계면활성제; 및0.001 to 2 parts by weight of a surfactant based on 100 parts by weight of the solid content of the photoresist composition; And 나머지 유기용매로 이루어진 포토레지스트 조성물.And the remaining organic solvent.
(a) 감광성 고분자 3 내지 30 중량%; 상기 감광성 고분자 100 중량부에 대하여 1 내지 30 중량부의 하기 화학식 1(여기서, R1은 C1 ~ C30의 선형, 분지형 또는 단일환형의 알킬기이고, R2는 C1 ~ C20의 분지형, 단일환형, 또는 다환형의 알킬기이다)로 표시되는 용해억제제;(a) 3 to 30% by weight of a photosensitive polymer; Wherein R 1 is a linear, branched or cyclic alkyl group having 1 to 30 carbon atoms, R 2 is a C1 to C20 branched, monocyclic, or cyclic alkyl group having 1 to 30 carbon atoms, Or a polycyclic alkyl group); [화학식 1] [Chemical Formula 1]
Figure 112014088818822-pat00065
Figure 112014088818822-pat00065
상기 감광성 고분자 100 중량부에 대하여 0.05 내지 10 중량부의 광산발생제; 전체 포토레지스트 조성물에 대하여, 0.01 내지 10 중량%의 염기성 화합물; 및 나머지 유기용매로 이루어진 포토레지스트 조성물을, 기판 상부에 도포하여, 포토레지스트막을 형성하는 단계;0.05 to 10 parts by weight of a photoacid generator based on 100 parts by weight of the photosensitive polymer; 0.01 to 10% by weight, relative to the total photoresist composition, of a basic compound; And a remaining organic solvent on the substrate to form a photoresist film; (b) 상기 포토레지스트막을 소정 패턴으로 노광하는 단계;(b) exposing the photoresist film to a predetermined pattern; (c) 상기 노광된 포토레지스트막을 가열하는 단계; 및(c) heating the exposed photoresist film; And (d) 상기 가열된 포토레지스트막을 현상하여 원하는 패턴을 얻는 단계를 포함하는 포토레지스트 패턴의 형성방법. (d) developing the heated photoresist film to obtain a desired pattern.
KR1020080033586A 2008-04-11 2008-04-11 Dissolution inhibitor and chemically amplified photoresist composition including the same KR101517763B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080033586A KR101517763B1 (en) 2008-04-11 2008-04-11 Dissolution inhibitor and chemically amplified photoresist composition including the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080033586A KR101517763B1 (en) 2008-04-11 2008-04-11 Dissolution inhibitor and chemically amplified photoresist composition including the same

Publications (2)

Publication Number Publication Date
KR20090108255A KR20090108255A (en) 2009-10-15
KR101517763B1 true KR101517763B1 (en) 2015-05-07

Family

ID=41551675

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080033586A KR101517763B1 (en) 2008-04-11 2008-04-11 Dissolution inhibitor and chemically amplified photoresist composition including the same

Country Status (1)

Country Link
KR (1) KR101517763B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013242397A (en) * 2012-05-18 2013-12-05 Fujifilm Corp Method for forming negative pattern, method for manufacturing electronic device, electronic device, and actinic ray-sensitive or radiation-sensitive resin composition
KR101966041B1 (en) 2018-06-14 2019-04-04 이영문 Bicycle with propulsion unit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100292406B1 (en) 1998-06-11 2001-07-12 윤종용 Photosensitive polymer and dissolution inhibitor for chemically amplified photoresist and chemically amplified photoresist composition having thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100292406B1 (en) 1998-06-11 2001-07-12 윤종용 Photosensitive polymer and dissolution inhibitor for chemically amplified photoresist and chemically amplified photoresist composition having thereof

Also Published As

Publication number Publication date
KR20090108255A (en) 2009-10-15

Similar Documents

Publication Publication Date Title
KR100604751B1 (en) Photoresist copolymer for preventing acid diffusion, and photoresist composition comprising the same
JP4808574B2 (en) Positive resist composition, resist pattern forming method and resin
JP5276805B2 (en) Resist composition and resist pattern forming method
JP2006259582A (en) Negative resist composition and resist pattern forming method
EP2240829B1 (en) Method of forming a patterned material on a substrate using ionic, organic photoacid generators for duv, muv and optical lithography based on peraceptor-substituted aromatic anions
JP4754265B2 (en) Positive resist composition and resist pattern forming method
KR20090049862A (en) Photosensitive compound and photoresist composition including the same
JP4144957B2 (en) Resist composition and method for forming resist pattern
KR20080037139A (en) Monomer for photoresist including sulfonyl group, polymer thereof and photoresist composition including the same
JP2008024671A (en) Compound, acid generator, resist composition and method for forming resist pattern
KR101259853B1 (en) Photosensitive Polymer and photoresist composition including the same
KR101517763B1 (en) Dissolution inhibitor and chemically amplified photoresist composition including the same
JP2008026838A (en) Positive resist composition and method for formation of resist pattern
KR101492403B1 (en) Dissolution accelerator and photoresist composition including the same
KR101207446B1 (en) Polymer for photoresist and photoresist composition including the same
US20090317741A1 (en) Compound, acid generator, resist composition and method of forming resist pattern
JP2008203612A (en) Negative resist composition and resist pattern forming method
JP4920271B2 (en) Positive resist composition and resist pattern forming method
JP5276821B2 (en) Resist composition and resist pattern forming method
JP2008107677A (en) Negative resist composition and method for forming resist pattern
JP2007057669A (en) Positive resist composition and resist pattern forming method
KR101287575B1 (en) Dissolution inhibitor and chemically amplified photoresist composition including the same
KR101184205B1 (en) Photo-sensitive compound, photo-sensitive polymer and chemically amplified photoresist composition including the same
KR100390986B1 (en) Multi-oxygen containing compound for preventing acid diffusion, and photoresist composition containing the same
JP4717732B2 (en) Positive resist composition and resist pattern forming method

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20180319

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20200309

Year of fee payment: 6